AIM at Melanoma Announces the Launch of AIM at Skin Cancer
…provide resources for the nonmelanoma community like those we provide for the melanoma community. We’re excited about this launch and…
AIM at Melanoma Announces the Launch of AIM at Skin Cancer
…provide resources for the nonmelanoma community like those we provide for the melanoma community. We’re excited about this launch and…
Relatlimab/Nivolumab Application for Frontline Advanced Melanoma Validated by EMA
…first step toward making it available for patients with advanced melanoma.” The global, double-blind, phase 2/3 RELATIVITY-047 trial enrolled 714…
,
,
Suzanne Lescure: One Woman, One Eye, One Extraordinary Survivor
…who worked in an office could work through a serious illness.” Treatment: Rarely just a straight shot Lescure had a…
,
COVID-19 Update
…have questions about melanoma, including melanoma and how it relates to COVID-19, please use our Ask a Melanoma Expert service. Melissa…
International Advocate Spotlight: Australia’s Tamara Dawson
…seriously enough, says Tamara Dawson, a Stage IV melanoma survivor. Tamara hopes to change that. After years of policy work…
,
,
International Advocate Spotlight: Claudia Piazza Cidonio
…of Melanoma. Melanoma Uruguay/Latin America and Melanoma Italia Onlus were officially founded in 2014, though Claudia’s advocacy work started before…
,
,
Notes from the Lab: T-Cell Engagers, the Next Stage in Cancer Immunotherapy?
…status explains why immune checkpoint blockade is effective for many patients with cutaneous melanoma. Uveal melanoma, on the other hand,…
,
Notes from the Lab: Novel targets for immune checkpoint inhibitors
…encounter melanoma cells and sense the threat. Inside of the melanoma tumor, the tumor cells will express the ligand of…
,
Melanoma By The State: Colorado
…there were 858 melanoma cases. In 2016, the total number of melanoma cases in Colorado was 1,290. The highest number…
,
Why Is the Tissue Bank So Important For Melanoma Research?
…Mohammed Kashani-Sabet’s research through the International Melanoma Tissue Bank Consortium (IMTBC) aims to identify the difference in gene signatures between…
,
Recent Posts
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026
Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors
Jun. 05, 2026